Table 1. Characteristics of Specimens by Tumor Site.

Tumor site	Number of specimens submitted for NGS	Specimens with DNA quality or quantity inadequate for NGS analysis	Number of “shared” specimens (i.e., results are available from both NGS and targeted tests)
Lung	196	13 (6.6%)	101 (51.5%)
Brain	174	9 (5.2%)	6 (3.4%)
Bone Marrow	161	0	95 (59.0%)
Lymph Node	70	8 (11.4%)	32 (45.7%)
Peripheral blood	56	0	29 (51.8%)
Liver	36	4 (11.1%)	5 (13.9%)
Skin	23	2 (8.7%)	5 (21.7%)
Other	222	24 (10.8%)	31 (14.0%)

Tumor site is not necessarily tissue of origin. Please note that in contrast to solid tumor specimens, all liquid specimens (bone marrow and peripheral blood) were adequate for NGS processing.